Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women.

ABSTRACT: In August 2012, the Centers for Disease Control and Prevention, in partnership with the Association of Maternal and Child Health Programs, convened a meeting of national subject matter experts to review key clinical elements of anthrax prevention and treatment for pregnant, postpartum, and lactating (P/PP/L) women. National experts in infectious disease, obstetrics, maternal fetal medicine, neonatology, pediatrics, and pharmacy attended the meeting, as did representatives from professional organizations and national, federal, state, and local agencies. The meeting addressed general principles of prevention and treatment for P/PP/L women, vaccines, antimicrobial prophylaxis and treatment, clinical considerations and critical care issues, antitoxin, delivery concerns, infection control measu

SUBMITTER: Meaney-Delman D 

PROVIDER: S-EPMC3901460 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature